MEC Plus Full List ViewBy pinki@katapult.biz / February 16, 2025 MEC Plus Events — 2025 MaTOS Breast 2025 MaTOS GU 2025 MCM 2025 PRIMO 2025 South Florida GI Cancer Symposium 2025 Winter Cancer Symposium (WCS) 2024 Advances in Oncology Conference 2024 Best of WCLC San Francisco 2024 California Cancer Consortium Conference (CCC) 2024 MaTOS Lungs 2024 MCM 2024 MLS Cleveland 2024 MLS Irvine 2024 MLS Nashville 2024 MLS New Orleans 2024 MLS Seattle 2024 New Orleans Summer Cancer Meeting (NOSCM) 2024 PACC Miami 2024 PRIMO 2024 SPS Puerto Rico 2024 SPS Seattle 2024 SPECTRUM 2024 Sylvester APP Oncology Symposium 2024 Updates in Cancer Therapies 2024 WCS Speciality — Amyotrophic Lateral Sclerosis (ALS) Biomarkers Biosimilars Bladder Blood Bone Brain Breast Cancer Central Nervous System (CNS) Clinical Trials Colon Colorectal Diversity, Equity & Inclusion Featured Content Gastrointestinal Genitourinary Genomic Geriatric Gynecology Head and Neck Hematologic Hematologic Maglinencies Hematology Immunotherapy Interventional Radiology Kidney Leukemia Liquid Biopsy Liver Lung Lymphoma Malignant Malignencies Melanoma Myelodysplastic Syndrome Myeloma Neuroendocrine Novel Oral & Maxillofacial Surgery Oral Cancer Ovarian Pancreas Pancreatic Pharmacological Prostate Radiation Radiology Renal Sarcoma Skin Solid Tumor Supportive & Palliative Care Survivorship Telemedicine Thoracic Thrombosis Thymic Thyroid Urothelial Type of Media — Video Document Audio Author / Speaker Title Search Entries: « 1 … 56 57 58 59 60 … 100 » What After Immunotherapy Failure in First Line: Is There Hope? Ticiana A. Leal, MD View PDF Stage IIIA-B-C NSCLC: Does The PACIFIC Data Fit All-in-One? Jorge E. Gomez, MD View PDF Favoring The Adjuvant Concept Heather A. Wakelee, MD View PDF Favoring The Neoadjuvant Concept Luis E. Raez, MD, FACP, FCCP View PDF Prostate Cancer: From Hormonal Manipulation to Targeted Therapy Ulka Vaishampayan, MD View PDF Pancreas and Biliary Carcinomas: Novel Advances Caio Max Rocha-Lima, MD, MS View PDF Colorectal Cancer: Chemotherapy Combinations Targeted Therapy and Immunotherapy Axel Grothey, MD View PDF Neurological Complications and Management in the Era of Checkpoint Inhibitors Michael T. Pulley, MD, PhD View PDF Management of Melanoma: Early and Advanced Stages Sanjiv Agarwala, MD View PDF Novel Advances in H&N and Thyroid Cancers Cesar Perez, MD View PDF Cancer and Thrombosis: State-of-the-Art Management Ted Wun, MD View PDF Pain Management in Cancer Patients Dennis Patin, MD View PDF Management of Metastatic Disease Using Interventional Radiology in 2023: Y90 SirSpheres and Other Procedures Timothy Yates, MD View PDF Most Common Adverse Events of Checkpoint Inhibitors | Current Recommendations and Management Meri Tarockoff, MD View PDF What Have We Learned from the Use Of Medical Marijuana: Myths and Facts Dov Pickholtz, DO View PDF Burkitt Lymphoma Leidy Isenalumhe, MD View Video Double Hit Lymphomas Julio Chavez, MD, MS View Video CNS Lymphomas Sepideh Mokhtari, MD View Video Current Standard of Therapies in CLL Javier Pinilla-Ibarz, MD, PhD View Video New Therapies for Follicular Lymphoma Sameh Gaballa, MD View Video The Rule of Immunotherapy in the Treatment of Relapse Hodgkin Lymphoma Hayder Saeed, MD View Video New Strategies for MCL Bijal Shah, MD, MS View Video Marginal Zone Lymphomas Sameh Gaballa, MD View Video DLBCL: Current Therapeutic Approaches Julio Chavez, MD, MS View Video PTCL: Evolving targeted therapies for mature T cell lymphoma Hayder Saeed, MD View Video CTCL: Micosis Fungoides & Sezary Syndrome Lubomir Sokol, MD, PhD View Video CDK4/6, PIK3CA & PARP Inhibitors in MBCA Stephanie L. Graff, MD View Video CDK4/6, PIK3CA & PARP Inhibitors in MBCA Stephanie L. Graff, MD View PDF Endocrine Therapy in the Neoadjuvant & Adjuvant Setting Vicente Valero, MD View PDF Endocrine Therapy in the Neoadjuvant & Adjuvant Setting Vicente Valero, MD View Video ← Previous View We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok
